North Zealand Hospital
Hillerød, 3400, Denmark
Location status: Recruiting
NCT Number: NCT07747896
The TSS project is a study of the effects of treating hard-to-heal ulcers in a multidisciplinary cross sectional team, meaning that nurse and doctor from a hospital based wound healing clinic and wound care nurse from the primary care sector treat the patient in collaboration rather than the current form where care in municipalities and hospital setting, communicate but treat the patient on their own. The study is designed as a randomized study, meaning that individuals with hard-to-heal ulcers are randomly designated to standard care or the multidis-ciplinary team. We measure several aspects of the new format, but the main outcome com-pared between the two groups (standard care and multidisciplinary care) is number of ulcers healed.
Participants are followed for a year after inclusion in the study, and have 6 fixed visits in the clinic, with the possibility of more visits if necessary.
There is no "new" medicine, surgery or other treatments planned in the study, but the multi-disciplinary team can offer and implement any treatment deemed appropriate for the individ-ual that is allocated to the multidisciplinary team, of course the individual has the opportunity to decline any treatment offered by the team. The control group, i.e. individuals allocated to standard care, will receive the treatment that is normally available to individuals with hard-to-heal ulcers treated in the municipality, including referral to hospital based treatments.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Hillerød, 3400, Denmark
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Revascularization procedure in the affected limb planned, or undertaken within the 4 weeks prior to screening
The proposed intervention consists of an MDT with an orthopedic surgeon (Jonas Askø Andersen) and a wound care nurse from the wound clinical at North Zealand Hospital as well as a wound care nurse from the primary sector. Participants who are randomized to intervention is offered treatment in the team as deemed appropriate by the MDT. The participant will be seen in the clinic (in the primary sector) for planned study visits at.
Participants randomized to control are not invited to be seen by the MDT team but are attended by the wound care nurse from the primary sector as part of the standard treatment offered to individuals with ulcers in the municipality. Apart from planned visits at 3, 6 and 12 months, the frequency and number of visits in the study period is performed as deemed appropriate by the wound care nurses from the primary sector. If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following healing date of event is noted.
Time frame: Ulcer healing at 12 months
Number of individuals that achieve healing of their hard-to-heal ulcer(s), compared between two arms
Time frame: 12 moths
Mean time (in days) to healing of healed hard-to-heal ulcer(s) in days - compared between groups
Time frame: 12 months
Incidence of recurrence of ulcer following healing of hard-to-heal ulcer(s) - compared between groups
Time frame: 12 months
Incidence of infections divided in
Time frame: 12 months
Incidence and amputations in total and divided in
Time frame: 12 months
Number of visits to clinics due to hard-to-heal ulcer(s) - compared between groups
Time frame: 12 months
Days admitted to hospital due to hard-to-heal ulcer(s) - compared between groups
Time frame: 12 months
Patient related outcomes (Wound-QoL) - compared between groups Wound-Qol is a PROM tool designed for patients living with chronic ulcers, and is scored on 17-items, from 0 to 4 for each item. The higher the score the worse the outcome. The scores are registered as a global score for all 17 items and divided in three subscales.
Time frame: 12 months
Cost effectiveness of intervention will be assessed by comparing expenditures between intervention and control group at four levels;
Time frame: 12 months
RE-AIM outcomes will be applied to assess implementation outcomes and is divided in five domains (first given here)
o Reach will be assessed using data available from Frederikssund Kommune on number of individuals with hard-to-heal ulcer(s) treated that can be reached with the cross-sectional MDT intervention in the municipality.
Time frame: 12 months
RE-AIM outcomes will be applied to assess implementation outcomes and is divided in five domains (second given here)
o Effect will be assessed by the clinical outcomes described above i.e., ulcer healing, infection etc.
Time frame: 12 months
RE-AIM outcomes will be applied to assess implementation outcomes and is divided in five domains (third given here)
o Adoption will be assessed on a local (NOHs catchment area), regional (the Capital Region of Denmark) and on a Danish level, by the number of clinics that have adopted the cross-sectional MDT model.
Time frame: 12 months
RE-AIM outcomes will be applied to assess implementation outcomes and is divided in five domains (fourth given here)
o Implementation will be assessed by the proportion of eligible individuals with hard-to-heal-ulcers offered the MDT-approach in Frederikssund Kommune.
Time frame: 12 months
RE-AIM outcomes will be applied to assess implementation outcomes and is divided in five domains (fifth given here)
o Maintenance will be assessed by how many of the clinics that have adopted the intervention actually maintain the intervention over time.
Contact information is provided by the study sponsor or research team.
Nordsjaellands Hospital
Other
Effect of a Coordinated Primary-care-Based MDT-model on the Treatment of Hard-to-heal Ulcers; a Randomized Clinically Controlled Trial
Acronym: TSS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07338773
Cardiovascular Diseases, Diabetes Complications
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07004179
Cardiovascular Diseases, Diabetes Complications
Palma de Mallorca, Balearic Islands, Spain
View Trial DetailsNCT06768554
Cardiovascular Diseases, Diabetes
Shanghai, China
View Trial DetailsNCT06777810
Cardiovascular Diseases, Diabetes
Shanghai, China
View Trial Details